Pavan Cheruvu
Vorstandsvorsitzender bei Bitterroot Bio, Inc.
Aktive Positionen von Pavan Cheruvu
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Bitterroot Bio, Inc.
Bitterroot Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Bitterroot Bio, Inc. is a company co-founded by Dr. Irv Weissman and Dr. Nick Leeper at Stanford University. The company is based in Palo Alto, CA. The company has closed a $145 million series A financing round co-led by Arch Venture Partners and Deerfield Management, with participation from GV, Koch Disruptive Technologies, Alexandria Venture Investments, and others. Bitterroot Bio's research has uncovered the critical roles that immune cells and modulators of inflammation play in the initiation and progression of cardiovascular disease. The company's lead candidate, BRB-002, targets the CD47/SIRP? pathway to address the underlying causes of atherosclerosis and vascular inflammation. The CEO of the company is Bruce Given. | Vorstandsvorsitzender | - | - |
Karriereverlauf von Pavan Cheruvu
Ehemalige bekannte Positionen von Pavan Cheruvu
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SIO GENE THERAPIES INC. | Direktor/Vorstandsmitglied | 26.09.2018 | 31.01.2022 |
Vorstandsvorsitzender | 12.02.2018 | 31.01.2022 | |
Technik-/Wissenschafts-/F&E-Leiter | - | 31.01.2022 | |
Präsident | - | 31.01.2022 | |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Vorstandsvorsitzender | 01.02.2018 | 01.12.2020 |
Ausbildung von Pavan Cheruvu
Duke University | Undergraduate Degree |
University of Oxford | Graduate Degree |
Harvard Medical School | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Vereinigtes Königreich | 2 |
Operativ
Chief Executive Officer | 3 |
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Consumer Services | 4 |
Health Technology | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Sio Gene Therapies, Inc.
Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
Axovant Sciences, Inc.
Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Health Technology |
Bitterroot Bio, Inc.
Bitterroot Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Bitterroot Bio, Inc. is a company co-founded by Dr. Irv Weissman and Dr. Nick Leeper at Stanford University. The company is based in Palo Alto, CA. The company has closed a $145 million series A financing round co-led by Arch Venture Partners and Deerfield Management, with participation from GV, Koch Disruptive Technologies, Alexandria Venture Investments, and others. Bitterroot Bio's research has uncovered the critical roles that immune cells and modulators of inflammation play in the initiation and progression of cardiovascular disease. The company's lead candidate, BRB-002, targets the CD47/SIRP? pathway to address the underlying causes of atherosclerosis and vascular inflammation. The CEO of the company is Bruce Given. | Commercial Services |
- Börse
- Insiders
- Pavan Cheruvu
- Erfahrung